Lakeside Secures New Distribution Agreements with Kelun Pharmaceutical
New Distribution Agreements: Lakeside Holding Limited's subsidiary, Hupan Pharmaceutical, has signed two distribution agreements with Hubei Kelun Pharmaceutical Trading Co., Ltd. to distribute large-volume parenteral solutions and related medical products across China for 2025.
Strengthening Market Position: These agreements build on previous partnerships, enhancing Hupan Pharmaceutical's portfolio and solidifying its role in the pharmaceutical distribution sector within the Asia-Pacific market.
Discover Tomorrow's Bullish Stocks Today
Analyst Views on LSH
About LSH
About the author

Lakeside Holding files to sell 7.4M shares of common stock for holders
Lakeside Holding Stock Offering: Lakeside Holding (LSH) has filed to sell 7.4 million shares of common stock for its holders.
Recent Company Developments: The company has announced board resignations and appointments, as well as secured new distribution agreements with Kelun Pharmaceutical.

LAKESIDE HOLDING ANNOUNCES A CONVERTIBLE DEBT FINANCING OF UP TO $4.5 MILLION
Securities Purchase Agreement: Lakeside Holding Limited has entered into a securities purchase agreement to sell up to $4.5 million in senior secured convertible promissory notes, with the first tranche generating approximately $930,000 in gross proceeds.
Company Overview: Lakeside is a U.S.-based supply chain solution provider focused on the Asia-Pacific market, operating through its subsidiaries American Bear Logistics and Hupan Pharmaceutical, enhancing its logistics capabilities in both general and pharmaceutical sectors.






